Godfrey Getz to Gene Expression Regulation
This is a "connection" page, showing publications Godfrey Getz has written about Gene Expression Regulation.
Connection Strength
0.227
-
Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis? Arterioscler Thromb Vasc Biol. 2016 09; 36(9):1734-41.
Score: 0.077
-
Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation. J Lipid Res. 2015 Feb; 56(2):215-26.
Score: 0.069
-
The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One. 2014; 9(10):e109252.
Score: 0.017
-
Differing rates of cholesterol absorption among inbred mouse strains yield differing levels of HDL-cholesterol. J Lipid Res. 2013 Sep; 54(9):2515-24.
Score: 0.016
-
A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol. 2011 Apr; 162(8):1792-804.
Score: 0.013
-
Apoprotein E biosynthesis in the cholesterol-fed guinea pig. Arteriosclerosis. 1990 Jan-Feb; 10(1):31-9.
Score: 0.012
-
Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther. 2008 Nov; 327(2):332-42.
Score: 0.011
-
Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis. 2009 Mar; 203(1):59-66.
Score: 0.011